Astellas

Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
With Iveric Bio buyout, Astellas CEO Okamura acted on the company's mantra to be 'aggressive'
Fierce Pharma
Tue, 06/13/23 - 10:43 am
Astellas
M&A
Iveric Bio
Naoki Okamura
Pharma CEOs
Astellas hit by US patent verdict for incontinence drug
Pharmaphorum
Mon, 06/12/23 - 10:23 am
Astellas
Myrbetriq
urinary incontinence
patents
legal
​Astellas Partners with Kate Therapeutics in Gene Therapy, After Four Patient Deaths in Previous Trials
BioSpace
Thu, 06/8/23 - 09:54 am
Astellas
Kate Therapeutics
gene therapy
X-linked myotubular myopathy
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Astellas
Iveric Bio
Bayer
Amgen
M&A
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Astellas, Sony Team on Novel ADC Platform for Oncology
BioSpace
Tue, 05/16/23 - 12:20 pm
Astellas
Sony Corporation
antibody-drug conjugate
oncology
Astellas' Menopause Drug Scores FDA Approval, After Regulatory Setback
Yahoo/Benzinga
Mon, 05/15/23 - 11:21 am
Astellas
FDA
hot flashes
Veozah
fezolinetant
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Astellas to acquire eye drug developer Iveric Bio for $5.9B
BioPharma Dive
Mon, 05/1/23 - 11:13 am
Astellas
M&A
Iveric Bio
eye health
Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients
Seeking Alpha
Mon, 05/1/23 - 10:13 am
Pfizer
Astellas
Xtandi
prostate cancer
clinical trials
FDA again delays Daiichi's plans to challenge Astellas and Novartis for blood cancer market
Fierce Biotech
Fri, 04/21/23 - 10:08 am
Daiichi Sankyo
Astellas
Novartis
quizartinib
FDA
blood cancer
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
Businesswire
Thu, 04/20/23 - 11:56 am
Twist Bioscience
Astellas
VHH antibodies
drug discovery
drug development
FDA Approves Keytruda/Padcev Combo in Advanced Urothelial Cancer
BioSpace
Tue, 04/4/23 - 12:35 pm
Merck
Seagen
Astellas
Keytruda
Padcev
metastatic urothelial carcinoma
FDA
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Sun, 03/26/23 - 03:36 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Drugs.com
Thu, 03/23/23 - 11:41 am
Astellas
zolbetuximab
clinical trials
gastric cancer
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
Fierce Pharma
Wed, 03/22/23 - 11:19 am
Pfizer
Astellas
Xtandi
prostate cancer
drug pricing
NIH
march-in rights
Pfizer and Astellas report positive data from prostate cancer therapy trial
Clinical Trials Arena
Fri, 03/17/23 - 10:02 am
Pfizer
Astellas
prostate cancer
clinical trials
Enzalutamide
leuprolide

Pages